Thompson Med buyout
Executive Summary
Management group, led by Chairman S. Daniel Abraham, proposed a $15 per share acquisition of the company's 7.5 mil. outstanding shares. Cash proposal is conditioned on execution of a definitive agreement, financing, and approval by the company's board and stockholders. The Abraham group controls about 70% of the firm. Thompson Med stock, which traded as high as $25 a share during the last 12 months, closed at 14-1/2 on Oct. 30, up 3-5/8.
|
Management group, led by Chairman S. Daniel Abraham, proposed a $15
per share acquisition of the company's 7.5 mil. outstanding shares.
Cash proposal is conditioned on execution of a definitive
agreement, financing, and approval by the company's board and
stockholders. The Abraham group controls about 70% of the firm.
Thompson Med stock, which traded as high as $25 a share during the
last 12 months, closed at 14-1/2 on Oct. 30, up 3-5/8. |